FGF-1: a human growth factor in the induction of neoangiogenesis
- 1 December 1998
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 7 (12) , 2011-2015
Abstract
Currently available approaches for treating human coronary heart disease aim to relieve symptoms and the risk of myocardial infarction either by reducing myocardial oxygen demand, preventing further disease progression, restoring coronary blood flow pharmacologically or mechanically, or bypassing the stenotic lesions and obstructed coronary artery segments. Gene therapy, especially using angiogenic growth factors, has emerged recently as a potential new treatment for cardiovascular disease. Following extensive experimental research on angiogenic growth factors, the first clinical studies on patients with coronary heart disease and peripheral vascular lesions have been performed. The polypeptides fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) appear to be particularly effective in initiating neovascularisation (neo-angiogenesis) in hypoxic or ischaemic tissues. The first clinical study on patients with coronary heart disease treated by local intramyocardial injection of FGF-1 ...Keywords
This publication has 20 references indexed in Scilit:
- Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusionJournal of Vascular Surgery, 1998
- Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by HypoxiaCirculation, 1996
- Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemiaSurgery, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardiumJACC, 1993
- Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth FactorScience, 1992
- Effects of acidic fibroblast growth factor on normal and ischemic myocardium.Circulation Research, 1991
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- Angiogenic FactorsScience, 1987